Hjem › Multipelt myelom › Californien › Baldwin Park
Multipelt myelom kliniske forsøg i Baldwin Park, CA
23 studier for Multipelt myelom søger deltagere på steder i og omkring Baldwin Park (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
RekruttererFase 1
- City of Hope National Medical Center /ID# 280273, Duarte · 4 mi væk
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
RekruttererFase 1
- City of Hope, Duarte · 4 mi væk
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
RekruttererFase 1/2
- City of Hope National Medical Center, Duarte · 4 mi væk
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
RekruttererFase 1
- Research Site, Duarte · 4 mi væk
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- City of Hope Duarte, Duarte · 4 mi væk
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
RekruttererFase 2
- City of Hope Medical Center, Duarte · 4 mi væk
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- City of Hope - Duarte, Duarte · 4 mi væk
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RekruttererFase 3
- City of Hope Duarte, Duarte · 4 mi væk
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RekruttererFase 4
- City of Hope, Duarte · 4 mi væk
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
RekruttererFase 3
- City of Hope National Medical Center, Duarte · 4 mi væk
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope, Duarte · 4 mi væk
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 1/2
- Research Site, Duarte · 4 mi væk
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
RekruttererFase 1/2
- Research Site, Duarte · 4 mi væk
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
RekruttererFase 1/2
- City of Hope, Duarte · 4 mi væk
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekruttererFase 1/2
- City of Hope National Medical Center /ID# 273132, Duarte · 4 mi væk
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi væk
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Rekrutterer
- City of Hope, Duarte · 4 mi væk
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
- City of Hope Medical Center, Duarte · 4 mi væk
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi væk
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi væk
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- City of Hope Medical Center, Duarte · 4 mi væk
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- City of Hope, Duarte · 4 mi væk
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi væk
Multipelt myelom forsøg i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Chicago, IL22 studier
- Seattle, WA22 studier
Andre studier i Baldwin Park
- Brystkræft45 studier
- Akut myeloid leukæmi40 studier
- Colorektal kræft38 studier
- Ikke-småcellet lungecancer36 studier
- Kræft (alle typer)33 studier
- Prostatakræft30 studier
- Metastatisk cancer30 studier
- Myelodysplastiske syndromer26 studier
- Ægstockræft25 studier
- Lungecancer24 studier
- Mavekræft22 studier
- Akut lymfoblastisk leukæmi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.